1st Quarter - Report
EPILEPSY FOUNDATION for EPILEPSY FOUNDATION
Firm
Client
Income
—
Expenses
$30,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Medicare and Medicaid Related Issues and Prescription Drug Policy Medicare Policy Reform Prescription Drug Access Issues Health Care Reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| DONNA MELTZER | Senior Government Relations Director |
| ANGELA OSTROM | Director, Federal Relations |
Veterans VET
Implementation of the VA Epilepsy Centers of Excellence Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| DONNA MELTZER | Director, Federal Relations |
| ANGELA OSTROM | Director, Federal Relations |
Budget/Appropriations BUD
Labor, HHS, Education and Related Agencies on epilepsy and health issues. Appropriations for NIH, CDCP, and HRSA, and funding for the Lifespan Respite Act. Research Funding for Epilepsy.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DONNA MELTZER | Senior Government Relations Director |
| ANGELA OSTROM | Director, Federal Relations |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.